{"entity":{"type":"insider","cik":"0001486672","url":"/insider/0001486672","json_url":"/insider/0001486672.json","name":"Myszkowski Kenneth Allen","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":51,"n_filings":27,"first":"2010-08-30","last":"2025-01-07","span_basis":"filed_date"},"name_variants":[{"name":"Myszkowski Kenneth Allen","source":"filing","n_filings":27,"first_seen":"2010-08-30","last_seen":"2025-01-07"}],"transactions":[{"id":4728416,"accession":"0001628280-25-000805","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001628280-25-000805","line_url":"/filing/0001628280-25-000805","is_derivative":false,"issuer_cik":"0000879407","issuer_name":"ARROWHEAD PHARMACEUTICALS, INC.","issuer_ticker":"ARWR","issuer_name_source":null,"issuer_url":"/issuer/0000879407","owner_cik":"0001486672","owner_name":"Myszkowski Kenneth Allen","owner_display_name":"Myszkowski Kenneth Allen","owner_url":"/insider/0001486672","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18000.0,"shares_display":"18,000","price_per_share":19.694444444444443,"price_display":"19.69","price_state":"stated","total_value":354500.0,"total_display":"354,500.00","total_whole":"354,500","shares_owned_after":455433.0,"shares_owned_after_display":"455,433","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-07","filed_date":"2025-01-07","scope":"insider","n_lines":2},{"id":4728396,"accession":"0001628280-25-000805","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001628280-25-000805","line_url":"/filing/0001628280-25-000805","is_derivative":false,"issuer_cik":"0000879407","issuer_name":"ARROWHEAD PHARMACEUTICALS, INC.","issuer_ticker":"ARWR","issuer_name_source":null,"issuer_url":"/issuer/0000879407","owner_cik":"0001486672","owner_name":"Myszkowski Kenneth Allen","owner_display_name":"Myszkowski Kenneth Allen","owner_url":"/insider/0001486672","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":27167.0,"shares_display":"27,167","price_per_share":19.825354290131408,"price_display":"19.83","price_state":"stated","total_value":538595.4,"total_display":"538,595.40","total_whole":"538,595","shares_owned_after":482835.0,"shares_owned_after_display":"482,835","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-06","filed_date":"2025-01-07","scope":"insider","n_lines":2},{"id":3058385,"accession":"0001628280-24-010062","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-24-010062","line_url":"/filing/0001628280-24-010062#line-1","is_derivative":false,"issuer_cik":"0000879407","issuer_name":"ARROWHEAD PHARMACEUTICALS, INC.","issuer_ticker":"ARWR","issuer_name_source":null,"issuer_url":"/issuer/0000879407","owner_cik":"0001486672","owner_name":"Myszkowski Kenneth Allen","owner_display_name":"Myszkowski Kenneth Allen","owner_url":"/insider/0001486672","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":40000.0,"shares_display":"40,000","price_per_share":35.19,"price_display":"35.19","price_state":"stated","total_value":1407600.0,"total_display":"1,407,600.00","total_whole":"1,407,600","shares_owned_after":400600.0,"shares_owned_after_display":"400,600","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-06","filed_date":"2024-03-08","scope":"insider"},{"id":2568100,"accession":"0001628280-24-000866","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001628280-24-000866","line_url":"/filing/0001628280-24-000866","is_derivative":false,"issuer_cik":"0000879407","issuer_name":"ARROWHEAD PHARMACEUTICALS, INC.","issuer_ticker":"ARWR","issuer_name_source":null,"issuer_url":"/issuer/0000879407","owner_cik":"0001486672","owner_name":"Myszkowski Kenneth Allen","owner_display_name":"Myszkowski Kenneth Allen","owner_url":"/insider/0001486672","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16104.0,"shares_display":"16,104","price_per_share":35.26512667660209,"price_display":"35.27","price_state":"stated","total_value":567909.6,"total_display":"567,909.60","total_whole":"567,910","shares_owned_after":440600.0,"shares_owned_after_display":"440,600","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-05","filed_date":"2024-01-08","scope":"insider","n_lines":3},{"id":7881355,"accession":"0001628280-23-023950","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-23-023950","line_url":"/filing/0001628280-23-023950#line-1","is_derivative":false,"issuer_cik":"0000879407","issuer_name":"ARROWHEAD PHARMACEUTICALS, INC.","issuer_ticker":"ARWR","issuer_name_source":null,"issuer_url":"/issuer/0000879407","owner_cik":"0001486672","owner_name":"Myszkowski Kenneth Allen","owner_display_name":"Myszkowski Kenneth Allen","owner_url":"/insider/0001486672","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":36.2,"price_display":"36.20","price_state":"stated","total_value":543000.0,"total_display":"543,000.00","total_whole":"543,000","shares_owned_after":381704.0,"shares_owned_after_display":"381,704","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-27","filed_date":"2023-06-29","scope":"insider"},{"id":6193395,"accession":"0001209191-22-063020","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-063020","line_url":"/filing/0001209191-22-063020#line-1","is_derivative":false,"issuer_cik":"0000879407","issuer_name":"ARROWHEAD PHARMACEUTICALS, INC.","issuer_ticker":"ARWR","issuer_name_source":null,"issuer_url":"/issuer/0000879407","owner_cik":"0001486672","owner_name":"Myszkowski Kenneth Allen","owner_display_name":"Myszkowski Kenneth Allen","owner_url":"/insider/0001486672","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30625.0,"shares_display":"30,625","price_per_share":40.0,"price_display":"40.00","price_state":"stated","total_value":1225000.0,"total_display":"1,225,000.00","total_whole":"1,225,000","shares_owned_after":336704.0,"shares_owned_after_display":"336,704","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-29","filed_date":"2022-12-30","scope":"insider"},{"id":6976439,"accession":"0001209191-22-002290","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-22-002290","line_url":"/filing/0001209191-22-002290","is_derivative":false,"issuer_cik":"0000879407","issuer_name":"ARROWHEAD PHARMACEUTICALS, INC.","issuer_ticker":"ARWR","issuer_name_source":null,"issuer_url":"/issuer/0000879407","owner_cik":"0001486672","owner_name":"Myszkowski Kenneth Allen","owner_display_name":"Myszkowski Kenneth Allen","owner_url":"/insider/0001486672","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":40000.0,"shares_display":"40,000","price_per_share":61.698524,"price_display":"61.70","price_state":"stated","total_value":2467940.96,"total_display":"2,467,940.96","total_whole":"2,467,941","shares_owned_after":471569.0,"shares_owned_after_display":"471,569","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-01-05","filed_date":"2022-01-06","scope":"insider","n_lines":4},{"id":4552712,"accession":"0001209191-21-003295","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-003295","line_url":"/filing/0001209191-21-003295#line-2","is_derivative":false,"issuer_cik":"0000879407","issuer_name":"ARROWHEAD PHARMACEUTICALS, INC.","issuer_ticker":"ARWR","issuer_name_source":null,"issuer_url":"/issuer/0000879407","owner_cik":"0001486672","owner_name":"Myszkowski Kenneth Allen","owner_display_name":"Myszkowski Kenneth Allen","owner_url":"/insider/0001486672","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1441.0,"shares_display":"1,441","price_per_share":81.0,"price_display":"81.00","price_state":"stated","total_value":116721.0,"total_display":"116,721.00","total_whole":"116,721","shares_owned_after":444005.0,"shares_owned_after_display":"444,005","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-12","filed_date":"2021-01-12","scope":"insider"},{"id":4552705,"accession":"0001209191-21-003295","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-003295","line_url":"/filing/0001209191-21-003295#line-1","is_derivative":false,"issuer_cik":"0000879407","issuer_name":"ARROWHEAD PHARMACEUTICALS, INC.","issuer_ticker":"ARWR","issuer_name_source":null,"issuer_url":"/issuer/0000879407","owner_cik":"0001486672","owner_name":"Myszkowski Kenneth Allen","owner_display_name":"Myszkowski Kenneth Allen","owner_url":"/insider/0001486672","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11597.0,"shares_display":"11,597","price_per_share":81.02,"price_display":"81.02","price_state":"stated","total_value":939588.94,"total_display":"939,588.94","total_whole":"939,589","shares_owned_after":445446.0,"shares_owned_after_display":"445,446","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-11","filed_date":"2021-01-12","scope":"insider"},{"id":4176021,"accession":"0001209191-21-002577","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-21-002577","line_url":"/filing/0001209191-21-002577","is_derivative":false,"issuer_cik":"0000879407","issuer_name":"ARROWHEAD PHARMACEUTICALS, INC.","issuer_ticker":"ARWR","issuer_name_source":null,"issuer_url":"/issuer/0000879407","owner_cik":"0001486672","owner_name":"Myszkowski Kenneth Allen","owner_display_name":"Myszkowski Kenneth Allen","owner_url":"/insider/0001486672","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30625.0,"shares_display":"30,625","price_per_share":72.44006563265306,"price_display":"72.44","price_state":"stated","total_value":2218477.01,"total_display":"2,218,477.01","total_whole":"2,218,477","shares_owned_after":457043.0,"shares_owned_after_display":"457,043","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-06","filed_date":"2021-01-07","scope":"insider","n_lines":3},{"id":2049371,"accession":"0001209191-20-058075","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-20-058075","line_url":"/filing/0001209191-20-058075","is_derivative":false,"issuer_cik":"0000879407","issuer_name":"ARROWHEAD PHARMACEUTICALS, INC.","issuer_ticker":"ARWR","issuer_name_source":null,"issuer_url":"/issuer/0000879407","owner_cik":"0001486672","owner_name":"Myszkowski Kenneth Allen","owner_display_name":"Myszkowski Kenneth Allen","owner_url":"/insider/0001486672","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":43505.0,"shares_display":"43,505","price_per_share":69.37295713136422,"price_display":"69.37","price_state":"stated","total_value":3018070.5,"total_display":"3,018,070.50","total_whole":"3,018,071","shares_owned_after":445333.0,"shares_owned_after_display":"445,333","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-09","filed_date":"2020-11-12","scope":"insider","n_lines":2},{"id":2838756,"accession":"0001209191-20-055599","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-055599","line_url":"/filing/0001209191-20-055599#line-2","is_derivative":false,"issuer_cik":"0000879407","issuer_name":"ARROWHEAD PHARMACEUTICALS, INC.","issuer_ticker":"ARWR","issuer_name_source":null,"issuer_url":"/issuer/0000879407","owner_cik":"0001486672","owner_name":"Myszkowski Kenneth Allen","owner_display_name":"Myszkowski Kenneth Allen","owner_url":"/insider/0001486672","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":29166.0,"shares_display":"29,166","price_per_share":54.04,"price_display":"54.04","price_state":"stated","total_value":1576130.64,"total_display":"1,576,130.64","total_whole":"1,576,131","shares_owned_after":427668.0,"shares_owned_after_display":"427,668","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-10-20","filed_date":"2020-10-22","scope":"insider"},{"id":2817558,"accession":"0001209191-20-004722","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001209191-20-004722","line_url":"/filing/0001209191-20-004722","is_derivative":false,"issuer_cik":"0000879407","issuer_name":"ARROWHEAD PHARMACEUTICALS, INC.","issuer_ticker":"ARWR","issuer_name_source":null,"issuer_url":"/issuer/0000879407","owner_cik":"0001486672","owner_name":"Myszkowski Kenneth Allen","owner_display_name":"Myszkowski Kenneth Allen","owner_url":"/insider/0001486672","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":40313.0,"shares_display":"40,313","price_per_share":49.43627688338749,"price_display":"49.44","price_state":"stated","total_value":1992924.63,"total_display":"1,992,924.63","total_whole":"1,992,925","shares_owned_after":387673.0,"shares_owned_after_display":"387,673","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-01-21","filed_date":"2020-01-23","scope":"insider","n_lines":6},{"id":3253220,"accession":"0001209191-20-002613","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-20-002613","line_url":"/filing/0001209191-20-002613","is_derivative":false,"issuer_cik":"0000879407","issuer_name":"ARROWHEAD PHARMACEUTICALS, INC.","issuer_ticker":"ARWR","issuer_name_source":null,"issuer_url":"/issuer/0000879407","owner_cik":"0001486672","owner_name":"Myszkowski Kenneth Allen","owner_display_name":"Myszkowski Kenneth Allen","owner_url":"/insider/0001486672","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":60.11003,"price_display":"60.11","price_state":"stated","total_value":1202200.6,"total_display":"1,202,200.60","total_whole":"1,202,201","shares_owned_after":391685.0,"shares_owned_after_display":"391,685","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-01-06","filed_date":"2020-01-08","scope":"insider","n_lines":3},{"id":8299891,"accession":"0001209191-19-054789","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-19-054789","line_url":"/filing/0001209191-19-054789","is_derivative":false,"issuer_cik":"0000879407","issuer_name":"ARROWHEAD PHARMACEUTICALS, INC.","issuer_ticker":"ARWR","issuer_name_source":null,"issuer_url":"/issuer/0000879407","owner_cik":"0001486672","owner_name":"Myszkowski Kenneth Allen","owner_display_name":"Myszkowski Kenneth Allen","owner_url":"/insider/0001486672","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":37884.0,"shares_display":"37,884","price_per_share":40.84515996198923,"price_display":"40.85","price_state":"stated","total_value":1547378.04,"total_display":"1,547,378.04","total_whole":"1,547,378","shares_owned_after":330156.0,"shares_owned_after_display":"330,156","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-11-01","filed_date":"2019-11-01","scope":"insider","n_lines":2},{"id":8598811,"accession":"0001209191-19-032137","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-032137","line_url":"/filing/0001209191-19-032137#line-1","is_derivative":false,"issuer_cik":"0000879407","issuer_name":"ARROWHEAD PHARMACEUTICALS, INC.","issuer_ticker":"ARWR","issuer_name_source":null,"issuer_url":"/issuer/0000879407","owner_cik":"0001486672","owner_name":"Myszkowski Kenneth Allen","owner_display_name":"Myszkowski Kenneth Allen","owner_url":"/insider/0001486672","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":27071.0,"shares_display":"27,071","price_per_share":22.0,"price_display":"22.00","price_state":"stated","total_value":595562.0,"total_display":"595,562.00","total_whole":"595,562","shares_owned_after":278536.0,"shares_owned_after_display":"278,536","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-05-21","filed_date":"2019-05-22","scope":"insider"},{"id":8674405,"accession":"0001209191-19-011831","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-011831","line_url":"/filing/0001209191-19-011831#line-2","is_derivative":false,"issuer_cik":"0000879407","issuer_name":"ARROWHEAD PHARMACEUTICALS, INC.","issuer_ticker":"ARWR","issuer_name_source":null,"issuer_url":"/issuer/0000879407","owner_cik":"0001486672","owner_name":"Myszkowski Kenneth Allen","owner_display_name":"Myszkowski Kenneth Allen","owner_url":"/insider/0001486672","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8000.0,"shares_display":"8,000","price_per_share":18.0,"price_display":"18.00","price_state":"stated","total_value":144000.0,"total_display":"144,000.00","total_whole":"144,000","shares_owned_after":305607.0,"shares_owned_after_display":"305,607","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-02-19","filed_date":"2019-02-20","scope":"insider"},{"id":8673819,"accession":"0001209191-19-004624","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-004624","line_url":"/filing/0001209191-19-004624#line-1","is_derivative":false,"issuer_cik":"0000879407","issuer_name":"ARROWHEAD PHARMACEUTICALS, INC.","issuer_ticker":"ARWR","issuer_name_source":null,"issuer_url":"/issuer/0000879407","owner_cik":"0001486672","owner_name":"Myszkowski Kenneth Allen","owner_display_name":"Myszkowski Kenneth Allen","owner_url":"/insider/0001486672","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":81875.0,"shares_display":"81,875","price_per_share":14.55,"price_display":"14.55","price_state":"stated","total_value":1191281.25,"total_display":"1,191,281.25","total_whole":"1,191,281","shares_owned_after":305607.0,"shares_owned_after_display":"305,607","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-01-17","filed_date":"2019-01-18","scope":"insider"},{"id":8388323,"accession":"0001209191-19-001476","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-001476","line_url":"/filing/0001209191-19-001476#line-2","is_derivative":false,"issuer_cik":"0000879407","issuer_name":"ARROWHEAD PHARMACEUTICALS, INC.","issuer_ticker":"ARWR","issuer_name_source":null,"issuer_url":"/issuer/0000879407","owner_cik":"0001486672","owner_name":"Myszkowski Kenneth Allen","owner_display_name":"Myszkowski Kenneth Allen","owner_url":"/insider/0001486672","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8333.0,"shares_display":"8,333","price_per_share":11.98,"price_display":"11.98","price_state":"stated","total_value":99829.34,"total_display":"99,829.34","total_whole":"99,829","shares_owned_after":387482.0,"shares_owned_after_display":"387,482","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-01-02","filed_date":"2019-01-03","scope":"insider"},{"id":6588052,"accession":"0001209191-18-050356","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-18-050356","line_url":"/filing/0001209191-18-050356","is_derivative":false,"issuer_cik":"0000879407","issuer_name":"ARROWHEAD PHARMACEUTICALS, INC.","issuer_ticker":"ARWR","issuer_name_source":null,"issuer_url":"/issuer/0000879407","owner_cik":"0001486672","owner_name":"Myszkowski Kenneth Allen","owner_display_name":"Myszkowski Kenneth Allen","owner_url":"/insider/0001486672","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":45000.0,"shares_display":"45,000","price_per_share":19.337777777777777,"price_display":"19.34","price_state":"stated","total_value":870200.0,"total_display":"870,200.00","total_whole":"870,200","shares_owned_after":330815.0,"shares_owned_after_display":"330,815","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-09-06","filed_date":"2018-09-10","scope":"insider","n_lines":2},{"id":6425456,"accession":"0001209191-18-038884","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-18-038884","line_url":"/filing/0001209191-18-038884#line-2","is_derivative":false,"issuer_cik":"0000879407","issuer_name":"ARROWHEAD PHARMACEUTICALS, INC.","issuer_ticker":"ARWR","issuer_name_source":null,"issuer_url":"/issuer/0000879407","owner_cik":"0001486672","owner_name":"Myszkowski Kenneth Allen","owner_display_name":"Myszkowski Kenneth Allen","owner_url":"/insider/0001486672","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":14.01,"price_display":"14.01","price_state":"stated","total_value":280200.0,"total_display":"280,200.00","total_whole":"280,200","shares_owned_after":310815.0,"shares_owned_after_display":"310,815","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-06-19","filed_date":"2018-06-20","scope":"insider"},{"id":6904129,"accession":"0001209191-18-034785","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-18-034785","line_url":"/filing/0001209191-18-034785#line-4","is_derivative":false,"issuer_cik":"0000879407","issuer_name":"ARROWHEAD PHARMACEUTICALS, INC.","issuer_ticker":"ARWR","issuer_name_source":null,"issuer_url":"/issuer/0000879407","owner_cik":"0001486672","owner_name":"Myszkowski Kenneth Allen","owner_display_name":"Myszkowski Kenneth Allen","owner_url":"/insider/0001486672","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12600.0,"shares_display":"12,600","price_per_share":11.0,"price_display":"11.00","price_state":"stated","total_value":138600.0,"total_display":"138,600.00","total_whole":"138,600","shares_owned_after":310815.0,"shares_owned_after_display":"310,815","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-05-31","filed_date":"2018-06-01","scope":"insider"},{"id":6904121,"accession":"0001209191-18-034785","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-18-034785","line_url":"/filing/0001209191-18-034785#line-2","is_derivative":false,"issuer_cik":"0000879407","issuer_name":"ARROWHEAD PHARMACEUTICALS, INC.","issuer_ticker":"ARWR","issuer_name_source":null,"issuer_url":"/issuer/0000879407","owner_cik":"0001486672","owner_name":"Myszkowski Kenneth Allen","owner_display_name":"Myszkowski Kenneth Allen","owner_url":"/insider/0001486672","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1400.0,"shares_display":"1,400","price_per_share":11.0,"price_display":"11.00","price_state":"stated","total_value":15400.0,"total_display":"15,400.00","total_whole":"15,400","shares_owned_after":310815.0,"shares_owned_after_display":"310,815","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-05-30","filed_date":"2018-06-01","scope":"insider"},{"id":6453742,"accession":"0001209191-18-021843","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-18-021843","line_url":"/filing/0001209191-18-021843#line-2","is_derivative":false,"issuer_cik":"0000879407","issuer_name":"ARROWHEAD PHARMACEUTICALS, INC.","issuer_ticker":"ARWR","issuer_name_source":null,"issuer_url":"/issuer/0000879407","owner_cik":"0001486672","owner_name":"Myszkowski Kenneth Allen","owner_display_name":"Myszkowski Kenneth Allen","owner_url":"/insider/0001486672","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":8.0,"price_display":"8.00","price_state":"stated","total_value":160000.0,"total_display":"160,000.00","total_whole":"160,000","shares_owned_after":310815.0,"shares_owned_after_display":"310,815","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-03-27","filed_date":"2018-03-27","scope":"insider"},{"id":9270116,"accession":"0001209191-16-138836","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-16-138836","line_url":"/filing/0001209191-16-138836#line-2","is_derivative":false,"issuer_cik":"0000879407","issuer_name":"ARROWHEAD PHARMACEUTICALS, INC.","issuer_ticker":"ARWR","issuer_name_source":null,"issuer_url":"/issuer/0000879407","owner_cik":"0001486672","owner_name":"Myszkowski Kenneth Allen","owner_display_name":"Myszkowski Kenneth Allen","owner_url":"/insider/0001486672","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6900.0,"shares_display":"6,900","price_per_share":8.0,"price_display":"8.00","price_state":"stated","total_value":55200.0,"total_display":"55,200.00","total_whole":"55,200","shares_owned_after":115689.0,"shares_owned_after_display":"115,689","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-08-23","filed_date":"2016-08-26","scope":"insider"},{"id":3257299,"accession":"0001209191-16-138541","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-16-138541","line_url":"/filing/0001209191-16-138541#line-4","is_derivative":false,"issuer_cik":"0000879407","issuer_name":"ARROWHEAD PHARMACEUTICALS, INC.","issuer_ticker":"ARWR","issuer_name_source":null,"issuer_url":"/issuer/0000879407","owner_cik":"0001486672","owner_name":"Myszkowski Kenneth Allen","owner_display_name":"Myszkowski Kenneth Allen","owner_url":"/insider/0001486672","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6900.0,"shares_display":"6,900","price_per_share":8.0,"price_display":"8.00","price_state":"stated","total_value":55200.0,"total_display":"55,200.00","total_whole":"55,200","shares_owned_after":115689.0,"shares_owned_after_display":"115,689","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-08-23","filed_date":"2016-08-24","scope":"insider"},{"id":9270117,"accession":"0001209191-16-138836","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-16-138836","line_url":"/filing/0001209191-16-138836#line-1","is_derivative":false,"issuer_cik":"0000879407","issuer_name":"ARROWHEAD PHARMACEUTICALS, INC.","issuer_ticker":"ARWR","issuer_name_source":null,"issuer_url":"/issuer/0000879407","owner_cik":"0001486672","owner_name":"Myszkowski Kenneth Allen","owner_display_name":"Myszkowski Kenneth Allen","owner_url":"/insider/0001486672","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13100.0,"shares_display":"13,100","price_per_share":8.0,"price_display":"8.00","price_state":"stated","total_value":104800.0,"total_display":"104,800.00","total_whole":"104,800","shares_owned_after":115689.0,"shares_owned_after_display":"115,689","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-08-22","filed_date":"2016-08-26","scope":"insider"},{"id":3257290,"accession":"0001209191-16-138541","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-16-138541","line_url":"/filing/0001209191-16-138541#line-2","is_derivative":false,"issuer_cik":"0000879407","issuer_name":"ARROWHEAD PHARMACEUTICALS, INC.","issuer_ticker":"ARWR","issuer_name_source":null,"issuer_url":"/issuer/0000879407","owner_cik":"0001486672","owner_name":"Myszkowski Kenneth Allen","owner_display_name":"Myszkowski Kenneth Allen","owner_url":"/insider/0001486672","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13100.0,"shares_display":"13,100","price_per_share":8.0,"price_display":"8.00","price_state":"stated","total_value":104800.0,"total_display":"104,800.00","total_whole":"104,800","shares_owned_after":115689.0,"shares_owned_after_display":"115,689","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-08-22","filed_date":"2016-08-24","scope":"insider"},{"id":2043363,"accession":"0001209191-16-088041","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-16-088041","line_url":"/filing/0001209191-16-088041#line-2","is_derivative":false,"issuer_cik":"0000879407","issuer_name":"ARROWHEAD RESEARCH CORP","issuer_ticker":"ARWR","issuer_name_source":null,"issuer_url":"/issuer/0000879407","owner_cik":"0001486672","owner_name":"Myszkowski Kenneth Allen","owner_display_name":"Myszkowski Kenneth Allen","owner_url":"/insider/0001486672","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":23347.0,"shares_display":"23,347","price_per_share":6.13,"price_display":"6.13","price_state":"stated","total_value":143117.11,"total_display":"143,117.11","total_whole":"143,117","shares_owned_after":85000.0,"shares_owned_after_display":"85,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-12-30","filed_date":"2016-01-04","scope":"insider"},{"id":6309357,"accession":"0001181431-14-029708","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001181431-14-029708","line_url":"/filing/0001181431-14-029708#line-3","is_derivative":false,"issuer_cik":"0000879407","issuer_name":"ARROWHEAD RESEARCH CORP","issuer_ticker":"ARWR","issuer_name_source":null,"issuer_url":"/issuer/0000879407","owner_cik":"0001486672","owner_name":"Myszkowski Kenneth Allen","owner_display_name":"Myszkowski Kenneth Allen","owner_url":"/insider/0001486672","role":"Officer (CFO)","role_mark":"O","role_mark_label":"Officer (CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":40000.0,"shares_display":"40,000","price_per_share":14.0215,"price_display":"14.02","price_state":"stated","total_value":560860.0,"total_display":"560,860.00","total_whole":"560,860","shares_owned_after":71500.0,"shares_owned_after_display":"71,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-08-15","filed_date":"2014-08-19","scope":"insider"},{"id":6489564,"accession":"0001181431-14-006597","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-14-006597","line_url":"/filing/0001181431-14-006597#line-2","is_derivative":false,"issuer_cik":"0000879407","issuer_name":"ARROWHEAD RESEARCH CORP","issuer_ticker":"ARWR","issuer_name_source":null,"issuer_url":"/issuer/0000879407","owner_cik":"0001486672","owner_name":"Myszkowski Kenneth Allen","owner_display_name":"Myszkowski Kenneth Allen","owner_url":"/insider/0001486672","role":"Officer (CFO)","role_mark":"O","role_mark_label":"Officer (CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16000.0,"shares_display":"16,000","price_per_share":18.7681,"price_display":"18.77","price_state":"stated","total_value":300289.6,"total_display":"300,289.60","total_whole":"300,290","shares_owned_after":71500.0,"shares_owned_after_display":"71,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-02-12","filed_date":"2014-02-12","scope":"insider"}],"collapsed":true,"next_cursor":"2014-02-12|6489564","ledger_fault":false,"count":{"value":51,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":1,"open_market":true},{"code":"S","label":"Open-market sale","n":50,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":51},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000879407","name":"ARROWHEAD PHARMACEUTICALS, INC.","url":"/issuer/0000879407","role":"Officer (Chief Financial Officer)","n_filings":27,"first_seen":"2010-08-30","last_seen":"2025-01-07"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001486672","retrieved_at":"2026-08-22T11:06:33+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}